Mitraclip Secondary Mr denied as not medically necessary by Blue Cross Blue Shield?
Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for mitraclip secondary mr are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Mitraclip Secondary Mr
## Why BCBS Denied MitraClip for Secondary Mitral Regurgitation as Not Medically Necessary
A medical-necessity denial means BCBS determined that the clinical documentation submitted does not establish that MitraClip transcatheter edge-to-edge repair (TEER) meets its coverage criteria for your specific situation. For secondary (functional) mitral regurgitation, this most commonly occurs when BCBS's reviewers find the record incomplete on one or more key elements: the severity of regurgitation, the degree of optimization of heart failure therapy, functional impairment, or the heart team's assessment of surgical risk and patient selection.
## Why This Denial Is Appealable
Medical-necessity denials are the most frequently reversed category on appeal because they turn on documentation adequacy, not a categorical coverage exclusion. If your cardiologist and heart failure team have followed a thorough evaluation process and your chart reflects the clinical picture accurately, a well-organized appeal that matches each criterion to each chart fact has a strong basis. The FDA-approved labeling for MitraClip defines the patient population; if your case fits that population, the denial rests on a documentation gap, not a coverage wall.
## Federal Appeal Framework
- Internal appeal: Submit within 180 days of the denial notice. BCBS must decide within 30 days (pre-service) or 60 days (post-service).
- External review (ACA §2719 / ERISA §503): If upheld internally, you may request independent external review. The federal window is approximately four months from the final internal denial. External reviewers apply generally accepted standards of care independent of the plan's policy language.
- Expedited review: If waiting for a standard decision would seriously jeopardize your health, request expedited review for a response typically within 72 hours.
## Documentation to Gather
1. Echocardiogram reports: Current imaging confirming the severity and mechanism of secondary MR; ensure the report explicitly grades severity and documents anatomy relevant to TEER eligibility per the FDA labeling — ask your cardiologist which measurements matter. 2. Heart failure treatment record: A comprehensive medication reconciliation showing every guideline-directed medical therapy, start dates, any dose adjustments, and your clinical response over time. 3. Functional status documentation: NYHA functional class recorded at each recent cardiology visit; objective measures such as six-minute walk or exercise testing if available. 4. Heart team evaluation note: A multidisciplinary structural heart or heart failure team note documenting surgical risk assessment and the rationale for TEER over surgery. 5. Prescriber medical-necessity letter: A detailed letter from your interventional cardiologist explaining how your anatomy, symptoms, and treatment history satisfy each element of BCBS's medical policy and the FDA labeling.
## Criteria-Mapping Structure
Request BCBS's medical policy for transcatheter mitral valve repair. Lay out every stated requirement in a table:
| BCBS Policy Criterion | Supporting Chart Document | Key Finding | |---|---|---| | MR severity grade | Echo report [date] | [Grading language from report] | | GDMT optimization | Cardiology notes + med list | [Duration and therapy details] | | Symptomatic status | Visit notes [dates] | [NYHA class documented] | | Surgical risk assessment | Heart team note | [Risk category and rationale] | | Anatomical eligibility per label | Echo + structural cardiology interpretation | [Anatomy confirmation] |
A complete row for each criterion leaves the reviewer no gap to sustain the denial.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied as not medically necessary of 17ohp Compounded
- Blue Cross Blue Shield denied as not medically necessary of AAT Augmentation
- Blue Cross Blue Shield denied as not medically necessary of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied as not medically necessary of Anti Cd 20 Ocrevus